In a recent Law360 article, Thompson Coburn attorneys Michele Kloeppel, Sarah Larson, and Christian Witte examined the potential impact of the SEC’s proposed rescission of Rule 14a-8 and the role states may play in shaping the future of
Latest from Thompson Coburn - Page 2
New York DOL Publishes Proposed Opioid Overdose Medication Regulations
Starting December 12, 2026, many New York employers must keep an opioid antagonist, an overdose reversal medication, available at the workplace.
Governor Hochul signed the law in December 2025. A February 2026 amendment clarified that the medication must be available
Mackenzie Wallace, Ashton Dietrich Examine Payer Pressures Facing Rural Hospitals
In a recent Chief Healthcare Executive article, Thompson Coburn Health Care attorneys Mackenzie Wallace and Ashton Dietrich examined the growing pressures rural hospitals face when negotiating with Medicare Advantage and commercial payers.
The article outlines key considerations surrounding network adequacy requirements, reimbursement
DOJ Issues New Directive Prioritizing Corporate Enforcement in the Fight Against Fraud
On October 1, 2026, the U.S. Department of Justice (“DOJ”) issued Directive 26-12, Corporate Enforcement in the Fight Against Fraud (the “Directive”), which sets out the priorities and approach that will govern the investigation and prosecution of corporate fraud by
What You Keep, AI Can Reach: Know Your Data Before You Connect a Tool
A Cybersecurity Awareness Month series from Thompson Coburn’s Data Governance, Privacy and Cybersecurity practice group
In 2020, a hacker went undetected for three months inside the network of Blackbaud, a South Carolina company that provides fundraising, financial, and administrative software
Thompson Coburn Attorneys Examine SEC’s Proposed Overhaul of Shareholder Proposal Rules
In a recent Law360 article, Thompson Coburn attorneys Brent Trame, Nabil Al-Khaled, and Christian Witte examine how recent SEC actions and a proposed rescission of Rule 14a-8 could significantly reshape the shareholder proposal process and corporate governance landscape.
A Hollow Claim: Federal Court Dismisses Reese’s Peanut Butter Pumpkins Class Action for Lack of Injury
Reese’s Peanut Butter Pumpkins may not have had the jack-o’-lantern faces pictured on their packaging, but a federal court concluded that those missing details did not give consumers a concrete injury sufficient to support a proposed class action.
In Vidal
Hello Farms, Goodbye $32 Million: Will Your Cannabis Contract Survive Federal Court?
The Sixth Circuit has wiped out a $31.8 million jury verdict that Hello Farms, a licensed Michigan cultivator, had won against Curaleaf subsidiaries for walking away from a supply contract. The court’s reasoning was direct: federal courts cannot enforce agreements
The 2020 Title IX Regulations Are Back in the CFR: Here’s What Changed, and What Didn’t
For some time, Title IX compliance has come with an odd disconnect. Institutions have been following the 2020 Title IX regulations, but the official text in the Code of Federal Regulations (CFR) still showed the 2024 rule that courts had
Seventh Circuit Holds Allulose-Based ‘Sugar Free’ Claim Not Preempted
What happens when the FDA says it won’t enforce a labeling rule, but the rule itself never changes? In Franco v. Chobani, LLC, 184 F.4th 599 (7th Cir. 2026), the Seventh Circuit answered: the rule still counts, and state-law claims